Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_assertion type Assertion NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_head.
- NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_assertion description "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_provenance.
- NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_assertion evidence source_evidence_literature NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_provenance.
- NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_assertion SIO_000772 16682723 NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_provenance.
- NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_assertion wasDerivedFrom gad-20150221 NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_provenance.
- NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_assertion wasGeneratedBy ECO_0000203 NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_provenance.